Restor Dent Endod.  2014 Feb;39(1):63-67.

Chronic maxillary sinusitis caused by root canal overfilling of Calcipex II

Affiliations
  • 1Department of Conservative Dentistry, Gangneung-Wonju National University College of Dentistry, Gangneung, Korea.
  • 2Department of Oral Pathology, Gangneung-Wonju National University College of Dentistry, Gangneung, Korea. sklee@kangnung.ac.kr

Abstract

This is a case report of chronic maxillary sinusitis caused by root canal overfilling of Calcipex II (Techno-Dent). A 60 year-old male complained of dull pain in the right maxillary molar area after complicated endodontic treatment using Calcipex II paste and was finally diagnosed with a chronic maxillary sinusitis through a clinical and radiological observation. In the biopsy examination, the periapical granuloma contained a lot of dark and translucent Calcipex II granules which were not stained with hematoxylin and eosin. They were usually engulfed by macrophages but rarely resorbed, resulting in scattering and migrating into antral mucosa. Most of the Calcipex II granules were also accumulated in the cytoplasms of secretory columnar epithelial cells, and small amount of Calcipex II granules were gradually secreted into sinus lumen by exocytosis. However, chronic granulomatous inflammation occurred without the additional recruitment of polymorphonuclear leukocytes (PMNs) and lymphocytes, and many macrophages which engulfed the Calcipex II granules were finally destroyed in the processes of cellular apoptosis. It is presumed that Calcipex II granules are likely to have a causative role to induce the granulomatous foreign body inflammation in the periapical region, and subsequently to exacerbate the chronic maxillary sinusitis in this study.

Keyword

Calcipex II; Foreign body granuloma; Maxillary sinusitis

MeSH Terms

Apoptosis
Biopsy
Cytoplasm
Dental Pulp Cavity*
Eosine Yellowish-(YS)
Epithelial Cells
Exocytosis
Foreign Bodies
Granuloma, Foreign-Body
Hematoxylin
Humans
Inflammation
Lymphocytes
Macrophages
Male
Maxillary Sinus*
Maxillary Sinusitis*
Middle Aged
Molar
Mucous Membrane
Neutrophils
Periapical Granuloma
Eosine Yellowish-(YS)
Hematoxylin

Figure

  • Figure 1 (a) Panorama radiographs and standard radiographs (inlet square) after temporary root canal dressing material using Calcipex II, which was spilled into the periapical area; (b) Panorama and standard radiographs (inlet square) in one and half year. Some Calcipex II granules were gradually migrated into maxillary sinus through the mucoperiosteal space, although their radiopacity was reduced.

  • Figure 2 Photomicrographs of Calcipex II-related periapical granuloma involving maxillary sinusitis. H&E stain. (a1) A huge lump of Calcipex II; (a2) The Calcipex II materials scattered into the surrounding fibrous tissue; (a3) High magnification of panel (a2), grayish black fine granular materials of Calcipex II in macrophages (arrows); (b1)Frequent dystrophic calcifications (arrows); (b2 and b3) Calcipex II granules (arrows) were diffusely found around the calcified materials without inflammatory reaction; (c1) Diffuse granulomatous inflammation in the sinus mucosa; (c2 and c3) High magnification of panel (c1), enlarged macrophages filled with Calcipex II granules; (d1) Tissue degeneration (asterisks) containing abundant Calcipex II granules; (d2 and d3) High magnification of panel (d1), exocytosis of Calcipex II granules into the antral cavity (arrows); (d3) Accumulation of Calcipex II granules (arrows) in the cytoplasms of ciliated columnar cells.


Reference

1. Kim JW, Cho KM, Park SH, Song SG, Park MS, Jung HR, Song JY, Kim YS, Lee SK. Overfilling of calcium hydroxide-based paste Calcipex II produced a foreign body granuloma without acute inflammatory reaction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 107:e73–e76.
Article
2. Hosoya N, Kurayama H, Iino F, Arai T. Effects of calcium hydroxide on physical and sealing properties of canal sealers. Int Endod J. 2004; 37:178–184.
Article
3. Manisali Y, Yücel T, Erişen R. Overfilling of the root. A case report. Oral Surg Oral Med Oral Pathol. 1989; 68:773–775.
Article
4. Eda S, Kawakami T, Hasegawa H, Watanabe I, Kato K. Clinico-pathological studies on the healing of periapical tissues in aged patients by root canal filling using pastes of calcium hydroxide added iodoform. Gerodontics. 1985; 1:98–104.
5. Nurko C, Garcia-Godoy F. Evaluation of a calcium hydroxide/iodoform paste (Vitapex) in root canal therapy for primary teeth. J Clin Pediatr Dent. 1999; 23:289–294.
6. Mohammed M, Saujanya KP, Deepak J, Sangameshwar S, Arun A, Laxmi U, Mahnoor K. Role of calcium hydroxide in endodontics: a review. Glob J Med Public Health. 2012; 1:66–70.
7. Lee JH, Baek SH, Bae KS. Evaluation of the cytotoxicity of calcium phosphate root canal sealers. J Korean Acad Conserv Dent. 2003; 28:295–302.
Article
8. Nair PN, Sjögren U, Krey G, Sundqvist G. Therapy-resistant foreign body giant cell granuloma at the periapex of a root-filled human tooth. J Endod. 1990; 16:589–595.
Article
9. Segura JJ, Llamas R, Rubio-Manzanares AJ, Jimenez-Planas A, Guerrero JM, Calvo JR. Calcium hydroxide inhibits substrate adherence capacity of macrophages. J Endod. 1997; 23:444–447.
Article
10. Verdon C, Holz J. Root canal obturation based on Sealapex calcium hydroxide. A clinical and radiological follow-up after 1 year. Schweiz Monatsschr Zahnmed. 1990; 100:829–834.
11. Soares J, Santos S, César C, Silva P, Sá M, Silveira F, Nunes E. Calcium hydroxide induced apexification with apical root development: a clinical case report. Int Endod J. 2008; 41:710–719.
Article
12. De Moor RJ, De Witte AM. Periapical lesions accidentally filled with calcium hydroxide. Int Endod J. 2002; 35:946–958.
Article
13. Lee Y. Effect of calcium hydroxide application time on dentin. Restor Dent Endod. 2013; 38:186.
Article
14. Cruz EV, Kota K, Huque J, Iwaku M, Hoshino E. Penetration of propylene glycol into dentine. Int Endod J. 2002; 35:330–336.
Article
15. McIntosh MP, Schwarting N, Rajewski RA. In vitro and in vivo evaluation of a sulfobutyl ether beta-cyclodextrin enabled etomidate formulation. J Pharm Sci. 2004; 93:2585–2594.
Article
16. Faergemann J, Swanbeck G. Treatment of onychomycosis with a propylene glycol-urea-lactic acid solution. Mycoses. 1989; 32:536–540.
Article
17. Horiguchi Y, Honda T, Fujii S, Matsushima S, Osaki Y. A case of allergic contact dermatitis from propylene glycol in an ultrasonic gel, sensitized at a leakage skin injury due to transcatheter arterial chemoembolization for hepatocellular carcinoma. Int J Dermatol. 2005; 44:681–683.
Article
18. Nater JP, Baar AJ, Hoedemaeker J. Histological aspects of skin reactions to propylene glycol. Contact Dermatitis. 1977; 3:181–185.
Article
19. Senthilmohan ST, McEwan MJ, Wilson PF, Milligan DB, Freeman CG. Real time analysis of breath volatiles using SIFT-MS in cigarette smoking. Redox Rep. 2001; 6:185–187.
Article
20. Bledsoe KA, Kramer AH. Propylene glycol toxicity complicating use of barbiturate coma. Neurocrit Care. 2008; 9:122–124.
Article
Full Text Links
  • RDE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr